Table 1 Reasons for OnabotulinumtoxinA discontinuation before 24 months
From: OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
Total | N = 23 (14.8 %) |
|---|---|
OnabotulinumtoxinA indepent AEs | 5 (3.2 %) |
Not effective | 8 (5.2 %) |
Pregnancy | 2 (1.3 %) |
Drop out | 3 (1.8 %) |
Personal reasons | 5 (3.2 %) |